COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0303394 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mehrdad Khezri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Global Public Health, New York University, New York, NY, United States of America. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Immunization, Secondary, Substance Abuse, Intravenous. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, US NIH/NIDA.
Abstract (Originalsprache)
Background
Persons who inject drugs (PWID) may be unengaged with healthcare services and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to chronic diseases and structural inequities. However, data on COVID-19 vaccine uptake, particularly booster vaccination, among PWID are limited. We examined COVID-19 vaccine uptake and factors associated with booster vaccination among PWID in New York City (NYC).
Methods
We recruited PWID using respondent-driven sampling from October 2021 to November 2023 in a survey that included HIV and SARS-CoV-2 antibodies testing. The questionnaire included demographics, COVID-19 vaccination and attitudes, and drug use behaviors.
Results
Of 436 PWID, 80% received at least one COVID-19 vaccine dose. Among individuals who received at least one COVID-19 vaccine dose, 95% were fully vaccinated. After excluding participants recruited before booster authorization for general adults started in NYC, and those who had never received an initial vaccination, 41% reported having received a COVID-19 booster vaccine dose. COVID-19 booster vaccination was significantly associated with having a high school diploma or GED (adjusted odds ratio ( aOR) 1.93; 95% confidence interval (CI) 1.09, 3.48), ever received the hepatitis A/B vaccine (aOR 2.23; 95% CI 1.27, 3.96), main drug use other than heroin/speedball, fentanyl and stimulants (aOR 14.4; 95% CI 2.32, 280), number of non-fatal overdoses (aOR 0.35; 95% CI 0.16, 0.70), and mean vaccination attitude score (aOR 0.94; 95% CI 0.89, 0.98).
Conclusions
We found a suboptimal level of COVID-19 booster vaccination among PWID, which was consistent with the rates observed in the general population in NYC and the U.S. Community-based interventions are needed to improve COVID-19 booster vaccination access and uptake among PWID. Attitudes towards vaccination were significant predictors of both primary and booster vaccination uptake. Outreach efforts focusing on improving attitudes towards vaccination and educational programs are essential for reducing hesitancy and increasing booster vaccination uptake among PWID.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Global Public Health, New York University, New York, NY, United States of America.
- HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
- Center for Drug Use and HIV/HCV Research, New York, NY, United States of America.
ORCID-Profile: Mehrdad Khezri, Chenziheng Allen Weng, Sarah Kimball
Förderung
- NIDA NIH HHS
- US NIH/NIDA
Zitieren
APA
Khezri, M., McKnight, C., Weng, C. A., Kimball, S., & Des Jarlais, D. (2024). COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City. PLOS ONE. https://doi.org/10.1371/journal.pone.0303394
Vancouver
Khezri M, McKnight C, Weng CA, Kimball S, Des Jarlais D. COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City. PLOS ONE. 2024. doi:10.1371/journal.pone.0303394
BibTeX
@article{Khezri2024,
author = {Khezri, Mehrdad and McKnight, Courtney and Weng, Chenziheng Allen and Kimball, Sarah and Des Jarlais, Don},
title = {COVID-19 vaccination uptake and determinants of booster vaccination among persons who inject drugs in New York City},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0303394}
}
EUVIMED